Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 3
2006 4
2007 5
2008 3
2009 2
2011 1
2012 1
2013 1
2015 1
2016 1
2018 1
2019 3
2020 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Preparation and characterization of lamotrigine containing nanocapsules for nasal administration.
Gieszinger P, Stefania Csaba N, Garcia-Fuentes M, Prasanna M, Gáspár R, Sztojkov-Ivanov A, Ducza E, Márki Á, Janáky T, Kecskeméti G, Katona G, Szabó-Révész P, Ambrus R. Gieszinger P, et al. Among authors: marki a. Eur J Pharm Biopharm. 2020 Aug;153:177-186. doi: 10.1016/j.ejpb.2020.06.003. Epub 2020 Jun 10. Eur J Pharm Biopharm. 2020. PMID: 32531424
Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
Alshweiat A, Csóka I, Tömösi F, Janáky T, Kovács A, Gáspár R, Sztojkov-Ivanov A, Ducza E, Márki Á, Szabó-Révész P, Ambrus R. Alshweiat A, et al. Among authors: marki a. Int J Pharm. 2020 Apr 15;579:119166. doi: 10.1016/j.ijpharm.2020.119166. Epub 2020 Feb 19. Int J Pharm. 2020. PMID: 32084574
Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach.
Katona G, Balogh GT, Dargó G, Gáspár R, Márki Á, Ducza E, Sztojkov-Ivanov A, Tömösi F, Kecskeméti G, Janáky T, Kiss T, Ambrus R, Pallagi E, Szabó-Révész P, Csóka I. Katona G, et al. Among authors: marki a. Pharmaceutics. 2020 Jan 25;12(2):97. doi: 10.3390/pharmaceutics12020097. Pharmaceutics. 2020. PMID: 31991767 Free PMC article.
Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia.
Bartos C, Ambrus R, Katona G, Sovány T, Gáspár R, Márki Á, Ducza E, Ivanov A, Tömösi F, Janáky T, Szabó-Révész P. Bartos C, et al. Among authors: marki a. Drug Des Devel Ther. 2019 Nov 28;13:4007-4020. doi: 10.2147/DDDT.S220876. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31819372 Free PMC article.
Allosteric activation of metabotropic glutamate receptor 5.
Jójárt B, Orgován Z, Márki Á, Pándy-Szekeres G, Ferenczy GG, Keserű GM. Jójárt B, et al. Among authors: marki a. J Biomol Struct Dyn. 2020 Jun;38(9):2624-2632. doi: 10.1080/07391102.2019.1638302. Epub 2019 Jul 17. J Biomol Struct Dyn. 2020. PMID: 31258022
Effect of solubility enhancement on nasal absorption of meloxicam.
Horváth T, Ambrus R, Völgyi G, Budai-Szűcs M, Márki Á, Sipos P, Bartos C, Seres AB, Sztojkov-Ivanov A, Takács-Novák K, Csányi E, Gáspár R, Szabó-Révész P. Horváth T, et al. Among authors: marki a. Eur J Pharm Sci. 2016 Dec 1;95:96-102. doi: 10.1016/j.ejps.2016.05.031. Epub 2016 May 31. Eur J Pharm Sci. 2016. PMID: 27260088
32 results